Robin L. Washington

2015

In 2015, Robin L. Washington earned a total compensation of $5.6M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,084,494
Option Awards$1,600,153
Salary$860,384
Stock Awards$2,004,702
Other$7,500
Total$5,557,233

Washington received $2M in stock awards, accounting for 36% of the total pay in 2015.

Washington also received $1.1M in non-equity incentive plan, $1.6M in option awards, $860.4K in salary and $7.5K in other compensation.

Rankings

In 2015, Robin L. Washington's compensation ranked 1,386th out of 13,638 executives tracked by ExecPay. In other words, Washington earned more than 89.8% of executives.

ClassificationRankingPercentile
All
1,386
out of 13,638
90th
Division
Manufacturing
482
out of 5,187
91st
Major group
Chemicals And Allied Products
177
out of 1,857
91st
Industry group
Drugs
135
out of 1,531
91st
Industry
Biological Products, Except Diagnostic Substances
20
out of 260
92nd
Source: SEC filing on March 28, 2016.

Washington's colleagues

We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2015.

2015

John Martin

Gilead Sciences

Chief Executive Officer

2015

John Milligan

Gilead Sciences

Chief Operating Officer

2015

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2015

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

News

You may also like